# CVS HEALTH CORPORATION (CVS) FY2024 Q1 Balance Sheet

- Company: CVS HEALTH CORPORATION (CVS)
- Period: As of 2024-03-31
- Filing: Q1 FY2024 10-Q, filed 2024-05-01, accession number 0000064803-24-000016
- Page: https://plicit.ai/financials/cvs/fy2024-q1-balance-sheet
- Chart image: https://plicit.ai/charts/cvs-fy2024-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2024-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 249,743,000,000 US dollars
- **Current assets**: 67,473,000,000 US dollars
- **Non-current assets**: 182,270,000,000 US dollars
- **Liabilities**: 175,593,000,000 US dollars
- **Current liabilities**: 83,319,000,000 US dollars
- **Non-current liabilities**: 92,274,000,000 US dollars
- **Equity**: 74,150,000,000 US dollars
- **Noncontrolling interest**: 182,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 32,217,000,000 US dollars
- **Inventories**: 16,346,000,000 US dollars
- **Cash and cash equivalents**: 9,801,000,000 US dollars
- **Other current assets**: 5,821,000,000 US dollars
- **Investments**: 3,288,000,000 US dollars
- **Goodwill**: 91,272,000,000 US dollars
- **Intangible assets, net**: 28,770,000,000 US dollars
- **Long-term investments**: 24,074,000,000 US dollars
- **Operating lease right-of-use assets**: 17,045,000,000 US dollars
- **Property and equipment, net**: 13,037,000,000 US dollars
- **Other assets**: 4,801,000,000 US dollars
- **Separate accounts assets**: 3,271,000,000 US dollars
- **Accrued expenses**: 22,350,000,000 US dollars
- **Pharmacy claims and discounts payable**: 22,289,000,000 US dollars
- **Health care costs payable**: 14,368,000,000 US dollars
- **Accounts payable**: 13,717,000,000 US dollars
- **Current portion of long-term debt**: 3,731,000,000 US dollars
- **Short-term debt**: 2,719,000,000 US dollars
- **Current portion of operating lease liabilities**: 1,906,000,000 US dollars
- **Other insurance liabilities**: 1,158,000,000 US dollars
- **Policyholders’ funds**: 1,081,000,000 US dollars
- **Long-term debt**: 57,694,000,000 US dollars
- **Long-term operating lease liabilities**: 15,742,000,000 US dollars
- **Other long-term liabilities**: 6,205,000,000 US dollars
- **Other long-term insurance liabilities**: 5,178,000,000 US dollars
- **Deferred income taxes**: 4,184,000,000 US dollars
- **Separate accounts liabilities**: 3,271,000,000 US dollars
- **Retained earnings**: 61,873,000,000 US dollars
- **Common stock, par value $0.01: 3,200 shares authorized; 1,771 shares issued and 1,252 shares outstanding at March 31, 2024 and 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and capital surplus**: 49,209,000,000 US dollars
- **Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding**: 0 US dollars
- **Noncontrolling interests**: 182,000,000 US dollars
- **Treasury stock, at cost: 519 shares at March 31, 2024 and 480 shares at December 31, 2023**: negative 36,773,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 341,000,000 US dollars
- **Gross equity (calculated)**: 111,264,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.